Johnson & Johnson stock heads into the open after a 1.1 percent gain

At the close on September 17, 2026, Johnson & Johnson stock finished higher on the NYSE, adding 1.1 percent with a close around USD 270. Volume stayed moderate as the broader S&P 500 also advanced more than 1 percent on the day.

Johnson & Johnson stock closed at USD 270.22 on the NYSE on September 17, 2026, up 1.1 percent from the previous close in a broadly positive US session. The move came as the S&P 500 gained about 1.1 percent on the same day, leaving the shares roughly in line with the wider market performance.

September 17, 2026 in numbers

Johnson & Johnson Inc. (ISIN US4781601046, NYSE: JNJ) ended the September 17, 2026 session at USD 270.22 after starting the day near USD 268, marking a modest advance as buyers added exposure late in the session. According to data cited by Zacks, the prior close stood at USD 267.28, implying a single-session gain of roughly USD 2.94. Intraday, the stock traded within a relatively tight range, with reports from Finanzen.ch indicating a session low around USD 268.00 and a high near USD 269.77 before the final print slightly above that band.

The broader backdrop was constructive for equities. Major US benchmarks advanced on September 17, 2026, with the S&P 500 rising about 1.1 percent to roughly 7,637 points, as summarized by AP News. Against this backdrop, Johnson & Johnson participated in the market upswing but did not significantly outpace the index, reflecting a steady rather than defensive or high-beta profile in the latest session.

Today’s drivers to watch

Today, September 18, 2026, Johnson & Johnson enters the pre-market window without a scheduled earnings release or major corporate event explicitly flagged for this date in recent investor commentary and calendar summaries. Dividend continuity and the company’s long record of annual payout increases remain part of the broader investment narrative, as highlighted by Yahoo Finance, but no specific dividend-related action is due today. On the market side, the strong close in US indices on September 17, 2026 and the ongoing focus on interest rate expectations and healthcare sector positioning may shape sentiment around Johnson & Johnson shares as traders head into today’s opening bell.